Literature DB >> 24954794

The immunological, environmental, and phylogenetic perpetrators of metastatic leishmaniasis.

Mary-Anne Hartley1, Stefan Drexler1, Catherine Ronet1, Stephen M Beverley2, Nicolas Fasel3.   

Abstract

Cutaneous leishmaniases have persisted for centuries as chronically disfiguring parasitic infections affecting millions of people across the subtropics. Symptoms range from the more prevalent single, self-healing cutaneous lesion to a persistent, metastatic disease, where ulcerations and granulomatous nodules can affect multiple secondary sites of the skin and delicate facial mucosa, even sometimes diffusing throughout the cutaneous system as a papular rash. The basis for such diverse pathologies is multifactorial, ranging from parasite phylogeny to host immunocompetence and various environmental factors. Although complex, these pathologies often prey on weaknesses in the innate immune system and its pattern recognition receptors. This review explores the observed and potential associations among the multifactorial perpetrators of infectious metastasis and components of the innate immune system.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Leishmania RNA virus; Toll-like receptor; cutaneous leishmaniasis; metastatic leishmaniasis; pattern recognition receptor; post-kala-azar dermal leishmaniasis

Mesh:

Year:  2014        PMID: 24954794      PMCID: PMC4287268          DOI: 10.1016/j.pt.2014.05.006

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  101 in total

1.  FLI1 polymorphism affects susceptibility to cutaneous leishmaniasis in Brazil.

Authors:  L Castellucci; S E Jamieson; E N Miller; L F de Almeida; J Oliveira; A Magalhães; L H Guimarães; M Lessa; E Lago; A R de Jesus; E M Carvalho; J M Blackwell
Journal:  Genes Immun       Date:  2011-06-02       Impact factor: 2.676

2.  A common polymorphism in TLR3 confers natural resistance to HIV-1 infection.

Authors:  Manuela Sironi; Mara Biasin; Rachele Cagliani; Diego Forni; Mariacristina De Luca; Irma Saulle; Sergio Lo Caputo; Francesco Mazzotta; Juan Macías; Juan A Pineda; Antonio Caruz; Mario Clerici
Journal:  J Immunol       Date:  2011-12-14       Impact factor: 5.422

3.  The MyD88 protein 88 pathway is differently involved in immune responses induced by distinct substrains of Leishmania major.

Authors:  Mélanie Revaz-Breton; Catherine Ronet; Annette Ives; Yazmin Hauyon-La Torre; Slavica Masina; Fabienne Tacchini-Cottier; Pascal Launois
Journal:  Eur J Immunol       Date:  2010-06       Impact factor: 5.532

Review 4.  Advances in leishmaniasis.

Authors:  Henry W Murray; Jonathan D Berman; Clive R Davies; Nancy G Saravia
Journal:  Lancet       Date:  2005 Oct 29-Nov 4       Impact factor: 79.321

5.  Association of mucosal leishmaniasis with HLA.

Authors:  M L Petzl-Erler; M P Belich; F Queiroz-Telles
Journal:  Hum Immunol       Date:  1991-12       Impact factor: 2.850

6.  Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis.

Authors:  Jorge Arevalo; Luis Ramirez; Vanessa Adaui; Mirko Zimic; Gianfranco Tulliano; César Miranda-Verástegui; Marcela Lazo; Raúl Loayza-Muro; Simonne De Doncker; Anne Maurer; Francois Chappuis; Jean-Claude Dujardin; Alejandro Llanos-Cuentas
Journal:  J Infect Dis       Date:  2007-05-03       Impact factor: 5.226

7.  Upregulation of surface proteins in Leishmania donovani isolated from patients of post kala-azar dermal leishmaniasis.

Authors:  Poonam Salotra; Robert C Duncan; Ruchi Singh; B V Subba Raju; Gannavaram Sreenivas; Hira L Nakhasi
Journal:  Microbes Infect       Date:  2006-01-11       Impact factor: 2.700

8.  Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection.

Authors:  Stephen E Girardin; Ivo G Boneca; Jérôme Viala; Mathias Chamaillard; Agnès Labigne; Gilles Thomas; Dana J Philpott; Philippe J Sansonetti
Journal:  J Biol Chem       Date:  2003-01-13       Impact factor: 5.157

9.  Leishmania induces survival, proliferation and elevated cellular dNTP levels in human monocytes promoting acceleration of HIV co-infection.

Authors:  David J Mock; Joseph A Hollenbaugh; Waaqo Daddacha; Michael G Overstreet; Chris A Lazarski; Deborah J Fowell; Baek Kim
Journal:  PLoS Pathog       Date:  2012-04-05       Impact factor: 6.823

10.  Toll-like receptors in leishmania infections: guardians or promoters?

Authors:  Marilia S Faria; Flavia C G Reis; Ana Paula C A Lima
Journal:  J Parasitol Res       Date:  2012-03-15
View more
  38 in total

1.  Profile of Stephen Beverley.

Authors:  Paul Gabrielsen
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-16       Impact factor: 11.205

2.  Zinc(II)-Dipicolylamine Coordination Complexes as Targeting and Chemotherapeutic Agents for Leishmania major.

Authors:  Douglas R Rice; Paola Vacchina; Brianna Norris-Mullins; Miguel A Morales; Bradley D Smith
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

3.  Antiviral screening identifies adenosine analogs targeting the endogenous dsRNA Leishmania RNA virus 1 (LRV1) pathogenicity factor.

Authors:  F Matthew Kuhlmann; John I Robinson; Gregory R Bluemling; Catherine Ronet; Nicolas Fasel; Stephen M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

4.  Diagnostic Efficacy of Molecular Techniques for Detection and Identification of Leishmania Species in Human Whole Blood and Skin Samples from Ecuador.

Authors:  Erika B Muñoz; Stephanie Santander; Patricio Rojas-Silva; Paul A Cardenas; Marco Fornasini; Sara C Cifuentes; Daniela Salvador; Manuel E Baldeón
Journal:  Am J Trop Med Hyg       Date:  2016-08-01       Impact factor: 2.345

5.  Concentration of 2'C-methyladenosine triphosphate by Leishmania guyanensis enables specific inhibition of Leishmania RNA virus 1 via its RNA polymerase.

Authors:  John I Robinson; Stephen M Beverley
Journal:  J Biol Chem       Date:  2018-03-06       Impact factor: 5.157

6.  Tilting the balance between RNA interference and replication eradicates Leishmania RNA virus 1 and mitigates the inflammatory response.

Authors:  Erin A Brettmann; Jahangheer S Shaik; Haroun Zangger; Lon-Fye Lye; F Matthew Kuhlmann; Natalia S Akopyants; Dayna M Oschwald; Katherine L Owens; Suzanne M Hickerson; Catherine Ronet; Nicolas Fasel; Stephen M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-18       Impact factor: 11.205

7.  Viral discovery and diversity in trypanosomatid protozoa with a focus on relatives of the human parasite Leishmania.

Authors:  Danyil Grybchuk; Natalia S Akopyants; Alexei Y Kostygov; Aleksandras Konovalovas; Lon-Fye Lye; Deborah E Dobson; Haroun Zangger; Nicolas Fasel; Anzhelika Butenko; Alexander O Frolov; Jan Votýpka; Claudia M d'Avila-Levy; Pavel Kulich; Jana Moravcová; Pavel Plevka; Igor B Rogozin; Saulius Serva; Julius Lukeš; Stephen M Beverley; Vyacheslav Yurchenko
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-28       Impact factor: 11.205

8.  Association of the Endobiont Double-Stranded RNA Virus LRV1 With Treatment Failure for Human Leishmaniasis Caused by Leishmania braziliensis in Peru and Bolivia.

Authors:  Vanessa Adaui; Lon-Fye Lye; Natalia S Akopyants; Mirko Zimic; Alejandro Llanos-Cuentas; Lineth Garcia; Ilse Maes; Simonne De Doncker; Deborah E Dobson; Jorge Arevalo; Jean-Claude Dujardin; Stephen M Beverley
Journal:  J Infect Dis       Date:  2015-06-29       Impact factor: 5.226

9.  Type I interferons induced by endogenous or exogenous viral infections promote metastasis and relapse of leishmaniasis.

Authors:  Matteo Rossi; Patrik Castiglioni; Mary-Anne Hartley; Remzi Onur Eren; Florence Prével; Chantal Desponds; Daniel T Utzschneider; Dietmar Zehn; Maria G Cusi; F Matthew Kuhlmann; Stephen M Beverley; Catherine Ronet; Nicolas Fasel
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

10.  Low frequency of LRV1 in Leishmania braziliensis strains isolated from typical and atypical lesions in the State of Minas Gerais, Brazil.

Authors:  Diego H Macedo; Armando Menezes-Neto; Jeronimo M Rugani; Ana C Rocha; Soraia O Silva; Maria N Melo; Lon-Fye Lye; Stephen M Beverley; Célia M Gontijo; Rodrigo P Soares
Journal:  Mol Biochem Parasitol       Date:  2016-08-18       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.